361 related articles for article (PubMed ID: 36106025)
1. Nanoparticle-based immunotherapy of pancreatic cancer.
Noubissi Nzeteu GA; Gibbs BF; Kotnik N; Troja A; Bockhorn M; Meyer NH
Front Mol Biosci; 2022; 9():948898. PubMed ID: 36106025
[TBL] [Abstract][Full Text] [Related]
2. Nanocarriers for pancreatic cancer imaging, treatments, and immunotherapies.
Liu L; Kshirsagar PG; Gautam SK; Gulati M; Wafa EI; Christiansen JC; White BM; Mallapragada SK; Wannemuehler MJ; Kumar S; Solheim JC; Batra SK; Salem AK; Narasimhan B; Jain M
Theranostics; 2022; 12(3):1030-1060. PubMed ID: 35154473
[TBL] [Abstract][Full Text] [Related]
3. Engineered nanomedicines to overcome resistance of pancreatic cancer to immunotherapy.
Elzoghby AO; Ferrone CR; Ferrone S; Nasr ML
Drug Discov Today; 2023 Jan; 28(1):103434. PubMed ID: 36368630
[TBL] [Abstract][Full Text] [Related]
4. The application of nanoparticles in cancer immunotherapy: Targeting tumor microenvironment.
Yang M; Li J; Gu P; Fan X
Bioact Mater; 2021 Jul; 6(7):1973-1987. PubMed ID: 33426371
[TBL] [Abstract][Full Text] [Related]
5. Advances in nano-immunotherapy for hematological malignancies.
Xu J; Liu W; Fan F; Zhang B; Sun C; Hu Y
Exp Hematol Oncol; 2024 May; 13(1):57. PubMed ID: 38796455
[TBL] [Abstract][Full Text] [Related]
6. Engineering Nanoparticles for Targeted Remodeling of the Tumor Microenvironment to Improve Cancer Immunotherapy.
Gao S; Yang D; Fang Y; Lin X; Jin X; Wang Q; Wang X; Ke L; Shi K
Theranostics; 2019; 9(1):126-151. PubMed ID: 30662558
[TBL] [Abstract][Full Text] [Related]
7. Nanoparticle-Based Immunotherapy for Reversing T-Cell Exhaustion.
Li F; Wang Y; Chen D; Du Y
Int J Mol Sci; 2024 Jan; 25(3):. PubMed ID: 38338674
[TBL] [Abstract][Full Text] [Related]
8. Engineered Nanomaterials for Tumor Immune Microenvironment Modulation in Cancer Immunotherapy.
Xing H; Li X
Chemistry; 2024 Jun; 30(32):e202400425. PubMed ID: 38576219
[TBL] [Abstract][Full Text] [Related]
9. Engineering the glioblastoma microenvironment with bioactive nanoparticles for effective immunotherapy.
Blanchard R; Adjei I
RSC Adv; 2023 Oct; 13(45):31411-31425. PubMed ID: 37901257
[TBL] [Abstract][Full Text] [Related]
10. Nanoparticle mediated cancer immunotherapy.
Gupta J; Safdari HA; Hoque M
Semin Cancer Biol; 2021 Feb; 69():307-324. PubMed ID: 32259643
[TBL] [Abstract][Full Text] [Related]
11. Molecular alterations and targeted therapy in pancreatic ductal adenocarcinoma.
Qian Y; Gong Y; Fan Z; Luo G; Huang Q; Deng S; Cheng H; Jin K; Ni Q; Yu X; Liu C
J Hematol Oncol; 2020 Oct; 13(1):130. PubMed ID: 33008426
[TBL] [Abstract][Full Text] [Related]
12. Do novel treatment strategies enhance T cell-mediated Immunity: Opportunities and challenges in pancreatic cancer immunotherapy.
Luo W; Zheng L; Zhang T
Int Immunopharmacol; 2021 Jan; 90():107199. PubMed ID: 33246828
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic challenges and current immunomodulatory strategies in targeting the immunosuppressive pancreatic tumor microenvironment.
Looi CK; Chung FF; Leong CO; Wong SF; Rosli R; Mai CW
J Exp Clin Cancer Res; 2019 Apr; 38(1):162. PubMed ID: 30987642
[TBL] [Abstract][Full Text] [Related]
14. Tumor microenvironment in chemoresistance, metastasis and immunotherapy of pancreatic cancer.
Wang S; Li Y; Xing C; Ding C; Zhang H; Chen L; You L; Dai M; Zhao Y
Am J Cancer Res; 2020; 10(7):1937-1953. PubMed ID: 32774994
[TBL] [Abstract][Full Text] [Related]
15. Shifting cold to hot tumors by nanoparticle-loaded drugs and products.
Ahmad I; Altameemi KKA; Hani MM; Ali AM; Shareef HK; Hassan ZF; Alubiady MHS; Al-Abdeen SHZ; Shakier HG; Redhee AH
Clin Transl Oncol; 2024 Jun; ():. PubMed ID: 38922537
[TBL] [Abstract][Full Text] [Related]
16. Non-viral nano-immunotherapeutics targeting tumor microenvironmental immune cells.
Yong SB; Chung JY; Song Y; Kim J; Ra S; Kim YH
Biomaterials; 2019 Oct; 219():119401. PubMed ID: 31398571
[TBL] [Abstract][Full Text] [Related]
17. Cancer cell membrane-wrapped nanoparticles for cancer immunotherapy: A review of current developments.
Jiang Q; Xie M; Chen R; Yan F; Ye C; Li Q; Xu S; Wu W; Jia Y; Shen P; Ruan J
Front Immunol; 2022; 13():973601. PubMed ID: 36105816
[TBL] [Abstract][Full Text] [Related]
18. Nanotechnology platforms for cancer immunotherapy.
Yang Z; Ma Y; Zhao H; Yuan Y; Kim BYS
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2020 Mar; 12(2):e1590. PubMed ID: 31696664
[TBL] [Abstract][Full Text] [Related]
19. Immunotherapy, Radiotherapy, and Hyperthermia: A Combined Therapeutic Approach in Pancreatic Cancer Treatment.
Mahmood J; Shukla HD; Soman S; Samanta S; Singh P; Kamlapurkar S; Saeed A; Amin NP; Vujaskovic Z
Cancers (Basel); 2018 Nov; 10(12):. PubMed ID: 30486519
[TBL] [Abstract][Full Text] [Related]
20. Engineering nanoparticle strategies for effective cancer immunotherapy.
Yoon HY; Selvan ST; Yang Y; Kim MJ; Yi DK; Kwon IC; Kim K
Biomaterials; 2018 Sep; 178():597-607. PubMed ID: 29576282
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]